Zhirong Shen, Ph.D.

VP, Global Head of Translational Discovery, Research and Medicine

Zhirong Shen joined BeiGene in August 2015 and is Vice President, Global Head of Translational Discovery, Research and Medicine. He is an experienced leader in drug discovery, translational research, and development. Prior to joining BeiGene, he was Director of Metabolomics Center at National Institute of Biological Sciences, Beijing (NIBS).

Dr. Shen received his B.S. in 2003 from Nanjing University and obtained his Ph.D. in Basic Biomedical Science in 2010 from the University of Texas Southwestern Medical Center at Dallas (UTSW). He completed his post-doctoral training at UTSW and NIBS with Dr. Xiaodong Wang. Dr. Shen’s research interests span broad areas, including cancer biology, cancer immunology, and drug resistance mechanisms of anti-cancer targeted therapy and immunotherapy.

 

You are now leaving BeiGene Australia


BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL